Korsana Biosciences Inc
D

KRSA

32.310
USD
1.01
(3.23%)
مفتوح الان
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
9,232
الربح لكل سهم
-8
العائد الربحي
-
P/E
-5
حجم السوق
1,471,443,442

العنوان: Korsana Biosciences Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibodythat combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.